Saracatinib (AZD0530): Mechanism of Action

Saracatinib (AZD0530) MOA:Targeting Fyn/Amyloid-beta Signaling Pathway for Alzheimer's Disease

🎯 check Saracatinib (AZD0530) product page

Saracatinib (AZD0530) is a potent, highly selective Src/Abl kinase inhibitor. It affects PI3K/AKT, Src/ERK, and JAK-STAT3 signaling pathways by blocking kinase activity and downstream phosphorylation, to inhibit tumor cell proliferation, migration, invasion, and fibrotic responses.

Primary Applications and Mechanism of Action